Axsome Therapeutics, Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · New York, NY
AXSM chart
What traders are saying about $AXSM
Latest postsAxsome Therapeutics, Inc. news
- Axsome Therapeutics (AXSM) Faces A Valuation Test Following Its CNS Growth Story
Simply Wall Street ·
- Rhythm Pharmaceuticals, Inc. (RYTM) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
Yahoo Finance ·
- Axsome Therapeutics, Inc. (AXSM) - What Are Researchers Saying About This Stock?
MarketBeat ·
- Axsome Therapeutics stock may move 8.6% on earnings report
Investing.com ·
- Axsome Therapeutics Is Maintained at Overweight by Piper Sandler
Moomoo ·
- Axsome Therapeutics stock may move 8.6% on earnings report By Investing.com
Investing.com South Africa ·
- Will Axsome Therapeutics (AXSM) Report Negative Earnings Next Week? What You Should Know
Yahoo Finance ·
- Axsome Therapeutics (NASDAQ:AXSM) Stock Price Target Cut by Piper Sandler
MarketBeat ·
- Axsome Therapeutics (AXSM) Projected to Post Quarterly Earnings on Monday
MarketBeat ·
- Washington Trust Advisors Inc. Buys 43,788 Shares of Axsome Therapeutics, Inc. $AXSM
MarketBeat ·
- Axsome Therapeutics, Inc. Estimates – NASDAQ:AXSM
TradingView ·
- Axsome Therapeutics Slides as Investors Await Q3 Results Amid Ongoing Biotech Pullback
Quiver Quantitative ·
Axsome Therapeutics, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $638.5M | $385.7M | $270.6M | $50.0M |
| Net income | -$183.2M | -$287.2M | -$239.2M | -$187.1M |
| Diluted EPS | $-3.68 | $-5.99 | $-5.27 | $-4.60 |
| Total assets (year end) | $689.8M | $568.5M | $588.2M | $331.5M |
| Cash and equivalents (year end) | $322.9M | $315.4M | $386.2M | $200.8M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Axsome Therapeutics, Inc.
- Ticker
- AXSM (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- New York, NY
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 1579428
Frequently asked questions
What exchange is Axsome Therapeutics, Inc. listed on?
Axsome Therapeutics, Inc. trades on the Nasdaq under the ticker symbol AXSM.
What industry is Axsome Therapeutics, Inc. in?
Axsome Therapeutics, Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Axsome Therapeutics, Inc. headquartered?
Axsome Therapeutics, Inc.'s business address on file with the SEC is in New York, NY.
When does Axsome Therapeutics, Inc.'s fiscal year end?
Axsome Therapeutics, Inc.'s fiscal year ends on December 31.
How much revenue did Axsome Therapeutics, Inc. report?
Axsome Therapeutics, Inc. reported $638.5M in revenue for calendar year 2025, according to its SEC filings.